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Background: The aim of this study was to evaluate the relationship between postprandial glucose level and
atherosclerosis in patients without diabetes and cardiovascular disease by determining carotid ultrasonographic
variables and serum levels of 1,5-anhydroglucitol (1,5-AG).
Methods: The subjects were 72 patients without diabetes and cardiovascular disease being treated for
hypertension or dyslipidemia. The clinical characteristics of all subjects, including the serum level of 1,5-AG, which
appears to be well suited for monitoring postprandial hyperglycemia, were evaluated after an overnight fast. The
average intima-media thickness (IMT) and the average pulsatility index (PI) of the right and left common carotid
arteries were determined with high-resolution ultrasonography and used as ultrasonographic variables. The subjects
were divided into a Lower 1,5-AG group (n = 36) and a Higher 1,5-AG group (n = 36). We evaluated the relationship
between clinical characteristics and ultrasonographic variables of the carotid artery in both groups.
Results: The average PI in the Lower 1,5-AG group was significantly higher than that in the Higher 1,5-AG group,
but the average IMT did not differ between the groups. Linear regression analysis, with the ultrasonographic
variables as the dependent variables, with 1,5-AG as the independent variable, and adjusted for other clinical
characteristics, showed significant correlation between 1,5-AG and the PI but not between 1,5-AG and IMT.
Conclusion: Our results suggest that postprandial hyperglycemia increases carotid artery stiffness, but not
morphological change, in patients without diabetes or cardiovascular disease.
Keywords: 1,5-anhydroglucitol, Pulsatility index, Postprandial glucose, Nondiabetic patientsBackground
Postprandial hyperglycemia is a major risk factor for mor-
bidity and mortality due to cardiovascular disease in
patients with diabetes [1,2]. Furthermore, in persons with
impaired glucose tolerance (IGT), postprandial hypergly-
cemia, but not fasting hyperglycemia, increases the risk of
cardiovascular disease [2]. Accordingly, decreasing post-
prandial hyperglycemia reduces the risk of cardiovascular
disease in persons with either IGT [3] or diabetes [2]. We
have recently found that brachial artery flow-mediated
dilation is reduced after glucose loading and is negatively* Correspondence: kentaro@nms.ac.jp
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reproduction in any medium, provided the orcorrelated with plasma glucose levels even in persons with
normal glucose tolerance [4]. Hence, to reduce the risk of
cardiovascular disease, the relationship between postpran-
dial hyperglycemia and cardiovascular risk factors, such as
atherosclerosis, should be evaluated. In fact, many tools
are available for evaluating and predicting cardiovascular
risk. For example, noninvasive ultrasonographic techniques
can be used to evaluate the severity of vascular damage
and to indicate the risk of progression of organ and vascu-
lar damage [5,6]. Carotid ultrasonography is a noninvasive
and inexpensive examination and is widely available in
outpatient clinics. The intima-media thickness (IMT) of
the carotid artery is an ultrasonographic variable useful
for evaluating vascular morphological changes and
predicting cardiovascular disease [7]. In addition, theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dynamic variable that is easily measured with Doppler
ultrasonography and is considered to reflect peripheral
aortic stiffness distal to the measurement point [8]. Hence,
the IMT and PI of the carotid artery are suitable variables
for morphological and functional assessment of carotid
atherosclerosis.
The aim of the present study was to evaluate the rela-
tionship between postprandial glucose levels and athero-
sclerosis in patients without diabetes or cardiovascular




The subjects were 72 patients (24 men and 48 women;
average age, 69.4 ± 10.7 years) without diabetes or car-
diovascular disease being treated for hypertension or
dyslipidemia at the outpatient clinic of our division. All
subjects were ambulatory and were free of anorexia or
stress conditions possibly affecting glycemic conditions.
All subjects were considered not to have diabetes be-
cause they met none of the following criteria in the past:
1) fasting plasma glucose level ≥ 7.0 mmol/L; 2) 2-hour
value ≥ 11.1 mmol/L on the 75-g oral glucose tolerance
test; 3) casual plasma glucose level of ≥ 11.1 mmol/L;
and 4) A1C (NGSP) ≥ 6.5%. The glycemic conditions of
all subjects were stable from the time of a non-diabetes
diagnosis to the start of the study period.
[9]. Furthermore, subjects were excluded on the basis
of the following criteria: pregnancy, previous gastrec-
tomy, anemia, severe illness, serum creatinine ≥ 114.92 -
μmol/L, urine protein test > 1+ (equivalent to > 0.3 g/L),
renal glucosuria, liver cirrhosis, chronic hepatitis, and
the use of drugs, such as oral hypoglycemic agents,
steroids, and traditional Chinese herbal medicines.
Study design
Informed consent and ethics regulations
The study design was approved by the Ethics Committee
of Nippon Medical School and carried out in accordance
with the principles of the Declaration of Helsinki. Before
the start of the study, written informed consent was
obtained from all subjects after they had received a clear
explanation of the study protocol.
Measurement of carotid ultrasonographic variables
The IMT and PI of CCA were determined as carotid
ultrasonographic variables as previously reported [10].
Carotid ultrasonographic measurements were performed
with a high-resolution ultrasonographic scanner and a
linear-array 8-MHz transducer (SSA-350A, Toshiba
Medical Systems, Co., Ltd, Tokyo, Japan). The IMT was
measured at a total of 4 segments clearly visualized withB-mode imaging of the near and far walls immediately
proximal to the carotid bifurcation in the right and left
CCAs. The average of the 4 IMT measurements was
calculated and defined as the IMT [11].
The PI of the CCA was determined with pulse Doppler
ultrasonography. Pulse Doppler volume measurements
were performed with a maximum angle of less than 60
degrees at the same points where the IMT had been
measured. The sample-volume measurement point was
placed at the center of CCA flow, and peak systolic flow
velocity (PSV), end-diastolic flow velocity (EDV), and
time-averaged flow velocity (TAV) were determined on the
basis of sample volumes. The PI was calculated as follows:
PI = (PSV-EDV)/TAV. The average of values from the right
and left CCAs was calculated and defined as the PI [10].
Carotid ultrasonographic measurements were performed
by 2 observers. The correlation coefficient for interobserver
reproducibility and the variability of measurements, re-
spectively, were r = 0.896 (P < 0.001) and 8.0% for the IMT
and r = 0.979 (P < 0.001) and 5.8% for the PI.
Measurement of pulse wave velocity
To evaluate the relationship between PI and vascular
stiffness, the pulse wave velocity (PWV) of the study
subjects was evaluated with an automated device (form
PWV/ABI; Omron Colin Co., Ltd., Tokyo, Japan) imme-
diately after the carotid ultrasonographic variables were
measured, as previously reported [12]. We measured
and evaluated the average right and left brachial-ankle
PWVs (baPWVs) of 58 of 72 study subjects.
Evaluation and classification of postprandial glucose levels
Postprandial glucose levels were determined on the basis
of 1,5-anhydroglucitol (1,5-AG), a major human polyol.
From 99% to 100% of 1,5-AG is reabsorbed in normogly-
cemia, but the reabsorption rate decreases significantly in
hyperglycemia in approximate proportion to the degree of
hyperglycemia above the renal threshold for glucosuria
[13,14]. Therefore, the serum level of 1,5-AG appears to
be well suited for monitoring glucose homeostasis in
patients with near-normoglycemia [15,16] or postprandial
hyperglycemia without fasting hyperglycemia [17,18]. Fur-
thermore, serum 1,5-AG level has been suggested to be
realted to microvascular and macrovascular complications
[14]. Subjects with conditions, other than postprandial
hyperglycemia, that effect serum 1,5-AG level had already
been excluded on the basis of exclusion criteria. The
serum 1,5-AG level was evaluated as previously reported
[19]: after an overnight fast the 1,5-AG level was
measured with an enzymatic method, (Lana 1,5-AG Auto
Liquid, Nippon Kayaku, Tokyo, Japan) with an automatic
clinical analyzer (model 7150, Hitachi High-Technologies
Corporation, Tokyo, Japan). The overnight fasting period
was defined as the 12 hours after the start of the last meal,
Table 1 Clinical characteristics of study subjects
Clinical characteristics Lower 1,5-AG group (n = 36) Higher 1,5-AG group (n = 36)
Male sex 13 (36.1) 11 (30.6)
Age (years) 70.9 ± 10.2 67.9 ± 11.2
BMI (kg/m2) 23.8 ± 4.0 24.0 ± 5.1
Smoking habit
None 20 (55.9) 25 (69.4)
Recent 10 (27.8) 6 (16.7)
Current 6 (16.7) 5 (13.9)
Hypertension 28 (77.8) 23 (63.9)
Statin use 16 (44.4) 14 (38.9)
Blood pressure (mm Hg)
Systolic 134.3 ± 16.1 131.0 ± 12.6
Diastolic 79.9 ± 7.2 81.8 ± 7.4
Total cholesterol (mmol/L) 5.42 ± 0.59 5.64 ± 1.14
HDL cholesterol (mmol/L) 1.46 ± 0.43 1.60 ± 0.43
Triglycerides (mmol/L) 1.58 ± 0.68 1.46 ± 0.85
Uric acid (μmol/L) 317.6 ± 98.2 342.4 ± 82.4
Serum creatinine (μmol/L) 71.0 ± 15.7 76.4 ± 15.6
FPG (mmol/L) 5.16 ± 0.40 5.15 ± 0.43
A1C (%) 5.66 ± 0.32 5.57 ± 0.28
1,5-AG (μg/mL)*** 12.71 ± 3.54 23.16 ± 3.82
Mean ± SD, n (%).
BMI: body-mass index; FPG: fasting plasma glucose; A1C: glycosylated hemoglobin; 1,5-AG: 1,5-anhydroglucitol.
***P < 0.001.
Table 2 Multivariate linear regression analysis assuming
PI as the dependent variable and 1,5-AG as the
independent variable
Pulsatility index β Coefficient (95% confidence interval) t-value
Model 1** −0.023 (−0.035 - -0.010) −3.639
Model 2** −0.018 (−0.030 - -0.006) −3.023
Model 3* −0.016 (−0.029 - -0.004) −2.637
Model 4* −0.017 (−0.029 - -0.004) −2.631
Model 5* −0.017 (−0.029 - -0.004) −2.619
Model 6* −0.018 (−0.031 - -0.004) −2.607
Model 7* −0.017 (−0.031 - -0.004) −2.583
Model 1, unadjusted; Model 2, adjusted for age and sex; Model 3, adjusted for
Model 2, BMI, and smoking habit; Model 4, adjusted for Model 3 and systolic
BP; Model 5, adjusted for Model 4, statin use, and total cholesterol; Model 6,
adjusted for Model 5 and serum creatinine; Model 7, adjusted for Model 6
and A1C.
*P < 0.05, **P < 0.01.
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levels, the subjects were divided into 2 groups: subjects
with lower serum 1,5-AG levels (Lower 1,5-AG group; n
= 36), and subjects with higher serum 1,5-AG levels
(Higher 1,5-AG group; n = 36).
Clinical characteristics of study subjects
The clinical characteristics evaluated were age, sex, body-
mass index (BMI), smoking habit, hypertension, statin use,
systolic and diastolic blood pressures, and biochemical
variables, including 1,5-AG and HbA1c (Japan Diabetes
Society [JDS]). Biochemical variables were evaluated after
an overnight fast. Serum total cholesterol, high-density
lipoprotein (HDL) cholesterol, triglycerides, uric acid, and
creatinine were measured with an automatic analyzer. The
HbA1C (JDS) was measured with high-performance liquid
chromatography (JDS Lot 3). Also, the HbA1c (JDS) was
transformed into A1C (NGSP) as follows: A1C (NGSP) =
HbA1c (JDS) + 0.4 [21].
Statistical analysis
The Mann-Whitney U-test was used to compare clinical
characteristics and ultrasonographic variables between the
Lower and Higher 1,5-AG groups. Multivariate linearregression analysis was used to identify associations be-
tween carotid ultrasonographic variables and serum 1,5-
AG levels. In this multivariate linear regression analysis, we
assumed that ultrasonographic variables were dependent
variables and that clinical characteristics, including the 1,5-
AG level, were independent variables. Data are presented
*P<0.05
Figure 1 The IMT and PI of subjects in the Lower and Higher 1,5-AG groups. A: Comparison of IMT between the Lower and Higher 1,5-AG
groups. B: Comparison of PI between the Lower and Higher 1,5-AG groups.
Watanabe et al. BMC Cardiovascular Disorders 2013, 13:11 Page 4 of 7
http://www.biomedcentral.com/1471-2261/13/11as means ± SD or β coefficients (95% confidence interval,
CI). Statistical significance was defined as P < 0.05. All ana-
lyses were performed with SPSS for Windows Ver. 12.0 J
(IBM SPSS Statistics, IBM Corp., Armonk, NY).Results
The average serum 1,5-AG level in the Lower 1,5-AG
group (12.71 ± 3.54 μg/mL) was significantly lower than
that in the Higher 1,5-AG group (23.16 ± 3.82 μg/mL,
P < 0.001, Table 1). However, no other clinical characteristics
differed significantly between the Lower and the Higher
1,5-AG groups.
The average IMT in the Lower 1,5-AG group (0.92 ±
0.17 mm) was higher, but not significantly so, than that in
the Higher 1,5-AG group (0.86 ± 0.14 mm; P = 0.066,
Figure 1A). On the other hand, the average PI in the
Lower 1,5-AG group (1.65 ± 0.43) was significantlyTable 3 Multivariate linear regression analysis assuming
IMT as the dependent variable and 1,5-AG as the
independent variable
Intima-media thickness β Coefficient
(95% confidence interval)
t-value
Model 1 −0.005 (−0.011 - 0.001) −1.749
Model 2 −0.002 (−0.007 - 0.003) −0.683
Model 3 −0.002 (−0.008 - 0.003) −0.810
Model 4 −0.002 (−0.007 - 0.003) −0.705
Model 5 −0.002 (−0.007 - 0.003) −0.785
Model 6 −0.001 (−0.006 - 0.005) −0.304
Model 7 −0.001 (−0.006 - 0.005) −0.287
Model 1, unadjusted; Model 2, adjusted for age and sex; Model 3, adjusted for
Model 2, BMI, and smoking habit; Model 4, adjusted for Model 3 and systolic
BP; Model 5, adjusted for Model 4, statin use, and total cholesterol; Model 6,
adjusted for Model 5 and serum creatinine;
Model7, adjusted for Model 6 and A1C.higher than that in the Higher 1,5-AG group (1.42 ± 0.25,
P = 0.013, Figure 1B).
Linear regression analysis adjusted for the subjects’
clinical characteristics showed significant correlations
between 1,5-AG and PI (β = −0.017, t = −2.583; P = 0.012,
Table 2) but not between 1,5-AG and IMT (Table 3).
Concerning baPWV in 58 study subjects, the average
baPWV in the Lower 1,5-AG group (1929.0 ± 489.9 cm/s,
n = 28) was higher, but not significantly so, than that
in Higher 1,5-AG group (1812.6 ± 328.2 cm/s, n = 30;
P = 0.673). However, PI was significantly correlated
with baPWV (r = 0.405; P = 0.002, Figure 2B). In contrast,
IMT was significantly, but weakly correlated with baPWV
(r = 0.305; P = 0.016, Figure 2A).Discussion
Our results demonstrate that the serum 1,5-AG level in
persons without diabetes or cardiovascular disease is sig-
nificantly correlated with the PI of the carotid artery but
not with the IMT.Figure 2 Correlations between baPWV and carotid
ultrasonographic variables. A: Correlation between IMT and
baPWV. B: Correlation between PI and baPWV.
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sclerosis [6]. In particular, several studies have shown that
the PI of the carotid artery is significantly correlated with
cerebrovascular disease [10,22,23]. Furthermore, the PI
of the carotid artery was significantly correlated with
Framingham risk scores in subjects with hypertension
[24], and systemic artery stiffness is correlated with carotid
artery stiffness [25], cardiovascular risk score, and the
presence of cardiovascular disease [26]. The present study
also found that the PI was significantly correlated with the
baPWW. Furthermore, aortic stiffness is an indicator of
cardiovascular disease, and high aortic stiffness is
correlated with an increased risk of cardiovascular events
[27]. On the other hand, reduced stiffness of the CCA is
associated with a reduced risk of cardiovascular events
[28]. Hence, the relation between carotid artery stiffness
and cardiovascular disease suggests that the increased PI
of the carotid artery in the present subjects is associated
with an increased risk of cardiovascular disease. Our
results in subjects without diabetes or cardiovascular
disease also suggest that the risk of cardiovascular dis-
ease is positively correlated with vascular stiffness,
which is induced by postprandial hyperglycemia, rather
than with the morphological changes of atherosclerosis.
In fact, Li et al. have found that the baPWV is increased in
subjects with IGT or newly diagnosed diabetes but not in
subjects with normal glucose tolerance or isolated
impaired fasting glucose [29]. Furthermore, Huang et al.
have found that the vascular stiffness of healthy individuals
is significantly and positively correlated with glucose levels
60 minutes after oral glucose challenge [30].
The mechanism of increased vascular stiffness in the
absence of the morphological changes of atherosclerosis
in the present study remains unclear. However, several
previous studies have provided important information
regarding the mechanism of how postprandial hypergly-
cemia increases vascular stiffness. Endothelium-derived
nitric oxide (NO) is considered an important factor in
the relaxation of vascular smooth muscle cells. The
proposed mechanism of relaxation is that NO induces
the hyperpolarization of smooth muscle cells by redu-
cing the open probability of Ca-channel–dependent acti-
vation of the sarcoplasmatic reticulum which, in turn,
decreases Ca2+ influx [31]. Many studies have found that
acute hyperglycemia is associated with increased oxida-
tive stress, which inactivates NO and contributes to
endothelial cell injury in vitro [32,33]. In particular,
Ceriello et al. have found that glucose levels fluctuating
over 24 hours are more deleterious to endothelial func-
tion and oxidative stress than are continuously high glu-
cose concentrations in healthy persons or patients with
type 2 diabetes [34]. Azuma et al. have shown that
repeated fluctuations in glucose or insulin increase mono-
cyte adhesion to the endothelium of the rat thoracic aortaand that stable hyperglycemia or hyperinsulinemia causes
less monocyte adhesion [35]. Furthermore, Ge et al. have
reported that oxidative stress under intermittently high
glucose conditions is significantly greater than that under
constantly high glucose conditions in vitro [36]. Such
differences have also been found in healthy subjects with
normal glucose tolerance [37-39] and in persons with IGT
[38,39] or diabetes [40,41]. In fact, we have previously
demonstrated that oral glucose loading attenuates brachial
artery flow-mediated dilation in persons with normal glu-
cose tolerance [4]. Our present findings in subjects without
the morphological changes of atherosclerosis suggest that
impaired NO bioactivity due to acute glucose elevation in
the postprandial state increases carotid vascular stiffness.
The present study had several limitations. First, we
could not assess the associations of OGTT plasma glu-
cose levels, with vascular stiffness. This relationship may
provide additional information against the results of the
present study. Second, we could not assess the relation-
ship between lipid metabolism and carotid artery
stiffness. Third, the final meal on the evening before the
study was not standardized. 1,5-AG in the body
originates mainly from foods and is well absorbed in the
intestine. The daily intake of 1,5-AG is approximately
26.8 μmol and is independent of food type (13.4 μmol/
100 kcal) [42]. On the other hand, the serum 1,5-AG
level is correlated with the daily urinary glucose excre-
tion level [16]. Therefore, a difference in energy intake
or the glycemic index might produce a difference in
daily urinary glucose excretion. Finally, the number of
subjects in our study was small; therefore, the results of
our study should be clarified in a larger population.
Conclusion
The results of the present study suggest that postprandial
hyperglycemia increases carotid vascular stiffness in
patients without diabetes or cardiovascular disease. Further
prospective study is needed to confirm these results.
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